|
1
|
Writing Group Members; Mozaffarian D,
Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de
Ferranti S, Després JP, Fullerton HJ, et al: Heart disease and
stroke statistics-2016 update: A report from the American Heart
Association. Circulation. 133:e38–360. 2016. View Article : Google Scholar
|
|
2
|
Guo X, Li Z, Vittinghoff E, Sun Y and
Pletcher MJ: Trends in rate of acute myocardial infarction among
patients aged <30 years. Nat Rev Cardiol. 15:1192018. View Article : Google Scholar
|
|
3
|
Plakht Y, Gilutz H and Shiyovich A: Excess
long-term mortality among hospital survivors of acute myocardial
infarction. Soroka Acute Myocardial Infarction (SAMI) project.
Public Health. 143:25–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bainey KR and Armstrong PW: Clinical
perspectives on reperfusion injury in acute myocardial infarction.
Am Heart J. 167:637–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gerczuk PZ and Kloner RA: An update on
cardioprotection: A review of the latest adjunctive therapies to
limit myocardial infarction size in clinical trials. J Am Coll
Cardiol. 59:969–978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neri M, Riezzo I, Pascale N, Pomara C and
Turillazzi E: Ischemia/reperfusion injury following acute
myocardial infarction: A critical issue for clinicians and forensic
pathologists. Mediators Inflamm. 2017:70183932017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: A delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F,
Wang NP, Guyton RA and Vinten-Johansen J: Inhibition of myocardial
injury by ischemic postconditioning during reperfusion: Comparison
with ischemic preconditioning. Am J Physiol Heart Circ Physiol.
285:H579–H588. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Donato M, Evelson P and Gelpi RJ:
Protecting the heart from ischemia/reperfusion injury: An update on
remote ischemic preconditioning and postconditioning. Curr Opin
Cardiol. 32:784–790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zou R, Shi W, Tao J, Li H, Lin X, Yang S
and Hua P: SIRT5 and post-translational protein modifications: A
potential therapeutic target for myocardial ischemia-reperfusion
injury with regard to mitochondrial dynamics and oxidative
metabolism. Eur J Pharmacol. 818:410–418. 2018. View Article : Google Scholar
|
|
12
|
Liu J, Wang H and Li J: Inflammation and
inflammatory cells in myocardial infarction and reperfusion injury:
A double-edged sword. Clin Med Insights Cardiol. 10:79–84. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Badalzadeh R, Mokhtari B and Yavari R:
Contribution of apoptosis in myocardial reperfusion injury and loss
of cardioprotection in diabetes mellitus. J Physiol Sci.
65:201–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morciano G, Bonora M, Campo G, Aquila G,
Rizzo P, Giorgi C, Wieckowski MR and Pinton P: Mechanistic role of
mPTP in ischemia-reperfusion injury. Adv Exp Med Biol. 982:169–189.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ong SB, Samangouei P, Kalkhoran SB and
Hausenloy DJ: The mitochondrial permeability transition pore and
its role in myocardial ischemia reperfusion injury. J Mol Cell
Cardiol. 78:23–34. 2015. View Article : Google Scholar
|
|
16
|
Hurst S, Hoek J and Sheu SS: Mitochondrial
Ca2+ and regulation of the permeability transition pore.
J Bioenerg Biomembr. 49:27–47. 2017. View Article : Google Scholar
|
|
17
|
Kwong JQ and Molkentin JD: Physiological
and pathological roles of the mitochondrial permeability transition
pore in the heart. Cell Metab. 21:206–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Šileikytė J and Forte M: Shutting down the
pore: The search for small molecule inhibitors of the mitochondrial
permeability transition. Biochim Biophys Acta. 1857.1197–1202.
2016.
|
|
19
|
Lim WY, Messow CM and Berry C: Cyclosporin
variably and inconsistently reduces infarct size in experimental
models of reperfused myocardial infarction: A systematic review and
meta-analysis. Br J Pharmacol. 165:2034–2043. 2012. View Article : Google Scholar :
|
|
20
|
Piot C, Croisille P, Staat P, Thibault H,
Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant
D, et al: Effect of cyclosporine on reperfusion injury in acute
myocardial infarction. N Engl J Med. 359:473–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rizvi F, Mathur A and Kakkar P: Morin
mitigates acetaminophen-induced liver injury by potentiating Nrf2
regulated survival mechanism through molecular intervention in
PHLPP2-Akt-Gsk3β axis. Apoptosis. 20:1296–1306. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Li Y, Xu H, Li G, Ma Y and Pang
YJ: Morin mitigates oxidative stress, apoptosis and inflammation in
cerebral ischemic rats. Afr J Tradit Complement Altern Med.
14:348–355. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang R, Kang KA, Piao MJ, Maeng YH, Lee
KH, Chang WY, You HJ, Kim JS, Kang SS and Hyun JW: Cellular
protection of morin against the oxidative stress induced by
hydrogen peroxide. Chem Biol Interact. 177:21–27. 2009. View Article : Google Scholar
|
|
24
|
Kastenmayer RJ, Moore RM, Bright AL,
Torres-Cruz R and Elkins WR: Select agent and toxin regulations:
Beyond the eighth edition of the Guide for the Care and Use of
Laboratory Animals. J Am Assoc Lab Anim Sci. 51:333–338.
2012.PubMed/NCBI
|
|
25
|
Wu N, Li W, Shu W and Jia D: Protective
effect of picroside II on myocardial ischemia reperfusion injury in
rats. Drug Des Devel Ther. 8:545–554. 2014.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔC T method. Methods. 25:402–408.
2001. View Article : Google Scholar
|
|
27
|
Strutyns’ka NA, Dorofeieva NO, Vavilova HL
and Sahach VF: Hydrogen sulfide inhibits Ca2+-induced
mitochondrial permeability transition pore opening in spontaneously
hypertensive rats. Fiziol Zh. 59:3–10. 2013.In Ukrainian.
View Article : Google Scholar
|
|
28
|
Nazari A, Sadr SS, Faghihi M, Azizi Y,
Hosseini MJ, Mobarra N, Tavakoli A and Imani A: Vasopressin
attenuates ischemia-reperfusion injury via reduction of oxidative
stress and inhibition of mitochondrial permeability transition pore
opening in rat hearts. Eur J Pharmacol. 760:96–102. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alizadeh AM, Faghihi M, Khori V, Sohanaki
H, Pourkhalili K, Mohammadghasemi F and Mohsenikia M: Oxytocin
protects cardiomyocytes from apoptosis induced by
ischemia-reperfusion in rat heart: Role of mitochondrial
ATP-dependent potassium channel and permeability transition pore.
Peptides. 36:71–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Al-Numair KS, Chandramohan G, Alsaif MA,
Veeramani C and El Newehy AS: Morin, a flavonoid, on lipid
peroxidation and antioxidant status in experimental myocardial
ischemic rats. Afr J Tradit Complement Altern Med. 11:14–20. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu CW, Yang F, Cheng SZ, Liu Y, Wan LH
and Cong HL: Rosuvastatin postconditioning protects isolated hearts
against ischemia-reperfusion injury: The role of radical oxygen
species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability
transition pore. Cardiovasc Ther. 35:3–9. 2017. View Article : Google Scholar
|
|
32
|
Xie Y, He Y, Cai Z, Cai J, Xi M, Zhang Y
and Xi J: Tauroursodeoxycholic acid inhibits endoplasmic reticulum
stress, blocks mitochondrial permeability transition pore opening,
and suppresses reperfusion injury through GSK-3β in cardiac H9c2
cells. Am J Transl Res. 8:4586–4597. 2016.
|
|
33
|
Wang Y, Yuan Y, Wang X, Wang Y, Cheng J,
Tian L, Guo X, Qin D and Cao W: Tilianin post-conditioning
attenuates myocardial ischemia/reperfusion injury via mitochondrial
protection and inhibition of apoptosis. Med Sci Monit.
23:4490–4499. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chanoit G, Zhou J, Lee S, McIntosh R, Shen
X, Zvara DA and Xu Z: Inhibition of phosphodiesterases leads to
prevention of the mitochondrial permeability transition pore
opening and reperfusion injury in cardiac H9c2 cells. Cardiovasc
Drugs Ther. 25:299–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Woodman OL, Long R, Pons S, Eychenne N,
Berdeaux A and Morin D: The cardioprotectant
3′,4′-dihydroxyflavonol inhibits opening of the mitochondrial
permeability transition pore after myocardial ischemia and
reperfusion in rats. Pharmacol Res. 81:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsujimoto Y and Shimizu S: Role of the
mitochondrial membrane permeability transition in cell death.
Apoptosis. 12:835–840. 2007. View Article : Google Scholar
|
|
37
|
Hüttemann M, Helling S, Sanderson TH,
Sinkler C, Samavati L, Mahapatra G, Varughese A, Lu G, Liu J,
Ramzan R, et al: Regulation of mitochondrial respiration and
apoptosis through cell signaling: Cytochrome c oxidase and
cytochrome c in ischemia/reperfusion injury and inflammation.
Biochim Biophys Acta. 1817.598–609. 2012.
|
|
38
|
Kim JS, He L and Lemasters JJ:
Mitochondrial permeability transition: A common pathway to necrosis
and apoptosis. Biochem Biophys Res Commun. 304:463–470. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang S, Li H, Tang L, Ge G, Ma J, Qiao Z,
Liu H and Fang W: Apelin-13 protects the heart against
ischemia-reperfusion injury through the RISK-GSK-3β-mPTP pathway.
Arch Med Sci. 11:1065–1073. 2015.PubMed/NCBI
|
|
40
|
Chen Z, Chua CC, Ho YS, Hamdy RC and Chua
BH: Overexpression of Bcl2 attenuates apoptosis and protects
against myocardial I/R injury in transgenic mice. Am J Physiol
Heart Circ Physiol. 280:H2313–H2320. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dejean LM, Martinez-Caballero S, Guo L,
Hughes C, Teijido O, Ducret T, Ichas F, Korsmeyer SJ, Antonsson B,
Jonas EA and Kinnally KW: Oligomeric Bax is a component of the
putative cytochrome c release channel MAC, mitochondrial
apoptosis-induced channel. Mol Biol Cell. 16:2424–2432. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM
and Zhou ZN: Intermittent hypoxia attenuates ischemia/reperfusion
induced apoptosis in cardiac myocytes via regulating Bcl2/Bax
expression. Cell Res. 13:385–391. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Imahashi K, Schneider MD, Steenbergen C
and Murphy E: Transgenic expression of Bcl2 modulates energy
metabolism, prevents cytosolic acidification during ischemia, and
reduces ischemia/reperfusion injury. Circ Res. 95:734–741. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hochhauser E, Kivity S, Offen D, Maulik N,
Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub
V, et al: Bax ablation protects against myocardial
ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart
Circ Physiol. 284:H2351–H2359. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Halestrap AP, Clarke SJ and Javadov SA:
Mitochondrial permeability transition pore opening during
myocardial reperfusion-a target for cardioprotection. Cardiovasc
Res. 61:372–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Javadov S, Karmazyn M and Escobales N:
Mitochondrial permeability transition pore opening as a promising
therapeutic target in cardiac diseases. J Pharmacol Exp Ther.
330:670–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
